Nov 07, 2024 / 01:30PM GMT
Operator
Good morning, ladies and gentlemen and welcome to the Chimerix third quarter, 2024 earnings conference call. I would now like to introduce you to your host for today's call. Will O'Connor from Stern Investor Relations. Please proceed.
Will O'Connor Stern Investor Relations
Thank you, operator. Good morning, everyone. And welcome to the Chimeric third quarter, 2024 financial and operating results conference call. This morning, we issued a press release related to our third quarter operating update. You can access the press release in our investors section of the website. With me on today's call are President and Chief executive of Officer Mike Andriole, Chief Scientific Officer Josh Allen, Chief Financial Officer Michelle LaSpaluto, Chief Medical Officer Allen Melemed and Chief operating and Commercial Officer Tom Riga.
For questions before we begin. I'd like to remind you that the statements made on today's call include forward statements within the meaning of the private securities Litigation Reform Act of 1,995 and are subject to risks and
Q3 2024 Chimerix Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot